MGC Pharmaceuticals Limited
MGC Pharmaceuticals Limited (MGCLF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MGCLF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMGC Pharmaceuticals Limited trailing twelve-month (TTM) revenue is $0.01B, a decrease of 28.40% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-06-30 | $0.00B | -$0.00B | -28.40% |
| 2022-06-30 | $0.00B | +$0.00B | +57.94% |
| 2021-06-30 | $0.00B | +$0.00B | +44.11% |
| 2020-06-30 | $0.00B | +$0.00B | +216.81% |
| 2019-06-30 | $0.00B | +$0.00B | +121.10% |
| 2018-06-30 | $0.00B | +$0.00B | +146.84% |
| 2017-06-30 | $0.00B | +$0.00B | +5373.01% |
| 2016-06-30 | $0.00B | +$0.00B | — |
| 2015-06-30 | $0.00B | -$0.00B | -100.00% |
| 2014-06-30 | $0.00B | -$0.00B | -55.74% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income MGC Pharmaceuticals Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
MGC Pharmaceuticals Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from MGC Pharmaceuticals Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MGCLF revenue · 4 questionsMGCLF's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 28.40% year-over-year from $0.00B in FY2023.
▸ Source: FMP · MGC Pharmaceuticals Limited SEC filings · GAAP · MGC Pharmaceuticals Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026